These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 15677501)
1. Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Steptoe RJ; Ritchie JM; Jones LK; Harrison LC Diabetes; 2005 Feb; 54(2):434-42. PubMed ID: 15677501 [TBL] [Abstract][Full Text] [Related]
2. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. Steptoe RJ; Ritchie JM; Harrison LC J Immunol; 2002 May; 168(10):5032-41. PubMed ID: 11994455 [TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799 [TBL] [Abstract][Full Text] [Related]
4. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. Slukvin II; Vodyanik MA; Thomson JA; Gumenyuk ME; Choi KD J Immunol; 2006 Mar; 176(5):2924-32. PubMed ID: 16493050 [TBL] [Abstract][Full Text] [Related]
5. GM-CSF expands dendritic cells and their progenitors in mouse liver. Pillarisetty VG; Miller G; Shah AB; DeMatteo RP Hepatology; 2003 Mar; 37(3):641-52. PubMed ID: 12601362 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Feili-Hariri M; Dong X; Alber SM; Watkins SC; Salter RD; Morel PA Diabetes; 1999 Dec; 48(12):2300-8. PubMed ID: 10580417 [TBL] [Abstract][Full Text] [Related]
7. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Kared H; Masson A; Adle-Biassette H; Bach JF; Chatenoud L; Zavala F Diabetes; 2005 Jan; 54(1):78-84. PubMed ID: 15616013 [TBL] [Abstract][Full Text] [Related]
8. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Li Q; Pan PY; Gu P; Xu D; Chen SH Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells induced in the presence of GM-CSF and IL-5. Yi H; Zhang L; Zhen Y; He X; Zhao Y Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554 [TBL] [Abstract][Full Text] [Related]
10. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Boudaly S; Morin J; Berthier R; Marche P; Boitard C Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. Nikolic T; Bunk M; Drexhage HA; Leenen PJ J Immunol; 2004 Oct; 173(7):4342-51. PubMed ID: 15383563 [TBL] [Abstract][Full Text] [Related]
13. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034 [TBL] [Abstract][Full Text] [Related]
14. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Lutz MB; Suri RM; Niimi M; Ogilvie AL; Kukutsch NA; Rössner S; Schuler G; Austyn JM Eur J Immunol; 2000 Jul; 30(7):1813-22. PubMed ID: 10940870 [TBL] [Abstract][Full Text] [Related]
15. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. Lu L; Woo J; Rao AS; Li Y; Watkins SC; Qian S; Starzl TE; Demetris AJ; Thomson AW J Exp Med; 1994 Jun; 179(6):1823-34. PubMed ID: 8195710 [TBL] [Abstract][Full Text] [Related]
16. GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes. Gaudreau S; Guindi C; Ménard M; Benabdallah A; Dupuis G; Amrani A Cell Immunol; 2010; 265(1):31-6. PubMed ID: 20637454 [TBL] [Abstract][Full Text] [Related]
17. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008 [TBL] [Abstract][Full Text] [Related]
18. Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. Hengesbach LM; Hoag KA J Nutr; 2004 Oct; 134(10):2653-9. PubMed ID: 15465762 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronan Binding Identifies a Functionally Distinct Alveolar Macrophage-like Population in Bone Marrow-Derived Dendritic Cell Cultures. Poon GF; Dong Y; Marshall KC; Arif A; Deeg CM; Dosanjh M; Johnson P J Immunol; 2015 Jul; 195(2):632-42. PubMed ID: 26085682 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication. Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]